Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357
Therapeutic Index01:13

Therapeutic Index

7.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.4K
Detection of Gross Error: The Q Test01:00

Detection of Gross Error: The Q Test

7.1K
When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
7.1K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

500
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
500

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Shining a light on chronic pain": A qualitative study of stakeholder views towards chronic pain at work and the Pain-at-Work Toolkit.

PloS one·2026
Same author

Reduction in sugar intake after the introduction of minimum unit pricing for alcohol in Scotland: a difference-in-differences analysis.

The American journal of clinical nutrition·2025
Same author

The gendered impact of Covid-19 on health behaviours and mental health: Evidence from the UK.

Social science & medicine (1982)·2024
Same author

Patient preferences for models of care for fibromyalgia: A discrete choice experiment.

PloS one·2024
Same author

The Web-Based Pain-at-Work Toolkit With Telephone Support for Employees With Chronic or Persistent Pain: Protocol for a Cluster Randomized Feasibility Trial.

JMIR research protocols·2023
Same author

Intra- and Extra-Hospitalization Monitoring of Vital Signs-Two Sides of the Same Coin: Perspectives from LIMS and Greenline-HT Study Operators.

Sensors (Basel, Switzerland)·2023

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.1K

The minimum clinically important difference for EQ-5D index: a critical review.

Silvia Coretti1, Matteo Ruggeri, Paul McNamee

  • 1Dr. Catholic University of Sacred Hearth - Faculty of Economics, L.go F. Vito 1, Rome 00168, Italy.

Expert Review of Pharmacoeconomics & Outcomes Research
|March 15, 2014
PubMed
Summary

The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is widely used to assess patient-reported health outcomes. This study reviews methods for estimating the minimum clinically important difference (MCID) for the EQ-5D, highlighting needs for standardization.

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.4K

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.1K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.4K

Area of Science:

  • Health Economics
  • Patient-Reported Outcomes
  • Psychometrics

Background:

  • The European Quality of Life-5 Dimensions Questionnaire (EQ-5D) is a leading instrument for valuing health outcomes from a patient's perspective.
  • Estimating the Minimum Clinically Important Difference (MCID) is crucial for interpreting the clinical significance of EQ-5D scores.
  • Existing research employs diverse methods to determine the MCID for the EQ-5D.

Purpose of the Study:

  • To provide a comprehensive overview of current methods for estimating the MCID of the three-level EQ-5D index using the UK scoring algorithm.
  • To critically evaluate the existing evidence on MCID estimation for the EQ-5D.
  • To identify areas for methodological improvement and standardization in MCID estimation.

Main Methods:

  • Systematic literature review of studies estimating MCID for the EQ-5D.
  • Critical assessment of the methodologies employed in the selected studies.
  • Analysis of the UK scoring algorithm's application in MCID estimation.

Main Results:

  • The estimation of MCID for the EQ-5D is an area of growing research interest.
  • A variety of approaches are currently used to estimate MCID, leading to potential inconsistencies.
  • The evidence base for MCID estimation using the UK scoring algorithm is critically assessed.

Conclusions:

  • Standardization of MCID estimation procedures for the EQ-5D is needed to improve cross-measure and cross-disease comparisons.
  • Further methodological research is required to bridge the gap between theoretical approaches and practical application of MCID.
  • Enhanced standardization will improve the utility of EQ-5D in clinical practice and health policy.